Evidence map›Paper›PMID 41772705›Full record

ReviewJournal of cheminformatics2026

Data curation in cheminformatics: importance and implementation.

Tsuyoshi Esaki, Kazuyoshi Ikeda

Abstract readReview
In one paragraph

Review in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tsuyoshi EsakiFaculty of Data Science, Shiga University, 1-1-1 Banba, Hikone, Shiga, 522-8522, Japan. tsuyoshi-esaki@biwako.shiga-u.ac.jp.
Kazuyoshi IkedaHPC- and AI-Driven Drug Development Platform Division, RIKEN Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan. kazuyoshi.ikeda@riken.jp.

Funding

Japan Agency for Medical Research and Development JP25ama121028Japan Science and Technology Agency National Bioscience Database Center JPMJND2401Japan Society for the Promotion of Science JP23K14382
6 · The paper itself

Abstract

Data curation is a fundamental yet often underappreciated aspect of cheminformatics and computational drug discovery. Large public and proprietary databases now provide vast amounts of chemical structure, physicochemical, absorption, distribution, metabolism, excretion, and toxicity (ADMET), and bioactivity data. However, these resources contain structural inconsistencies, annotation errors, and heterogeneous experimental conditions that can limit model performance and reproducibility. This narrative review summarizes why and how data should be curated before use in cheminformatics workflows. We frame chemical data curation around two complementary pillars: structural curation and curation of experimental conditions. On the structural side, we review existing standardization and quantitative structure-activity relationship (QSAR)-ready workflows, including handling of salts and mixtures, parent-child policies, aromatization, tautomer handling, stereochemistry validation, and duplicate detection with conflict resolution. On the experimental side, we synthesize evidence that assay protocols, measurement methods, and reporting practices introduce substantial uncertainty and bias in physicochemical and ADMET endpoints as well as bioactivity data, and we outline practical strategies for assembling condition-aware datasets from the literature and public databases. Across case studies, we highlight how curated structure-condition pairs yield more accurate, robust, and reproducible models than raw, unfiltered collections. Rather than introducing a new predictive method or performing a formal statistical meta-analysis, we provide a structured narrative synthesis of current best practices, tools, and decision points for data curation in cheminformatics. This review offers practical, evidence-based guidance on the structural and experimental-condition curation required to build reliable cheminformatics models.Scientific Contribution: This article does not introduce a new algorithm but provides a practice-oriented, structured synthesis of data curation in cheminformatics. We (i) formulate a two-pillar framework that treats structural curation and experimental-condition curation as equally important components of cheminformatics workflows; (ii) consolidate scattered best practices into concrete workflows, checklists, and decision maps for building "QSAR-ready" and condition-aware datasets; and (iii) integrate endpoint-specific case studies showing that rigorous curation materially improves predictive performance and reproducibility. We also identify open challenges and research directions for scaling and automating curation, including the use of workflow technologies and large language models, and for establishing community standards for condition metadata.

Indexed as

ADMETData curationIn silicoQSARStructure standardization

Identifiers

PMID41772705
PMCPMC13059370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.